Abbisko Therapeutics Shares Promising Results from Phase 2 Study of Lavengratinib for Achondroplasia #China #Shanghai #Abbisko #achondroplasia #Lavengratinib
@newsen.bsky.socialExplore
@newsen.bsky.social
@newsen.bsky.socialAbbisko Therapeutics Shares Promising Results from Phase 2 Study of Lavengratinib for Achondroplasia #China #Shanghai #Abbisko #achondroplasia #Lavengratinib